News for Healthier Living

MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma

Results from study of cancer treatment vaccine that originated at Roswell Park show significant survival benefit in glioblastoma patients 65 and under.

October 7, 2026


October 10 2026

October 9 2026

October 8 2026

October 7 2026

October 6 2026

October 5 2026

October 2 2026

October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026